Weilin Liu | Neuroscience | Best Researcher Award

Prof. Weilin Liu | Neuroscience | Best Researcher Award

The Institution of Rehabilitation Industry from Fujian University of Traditional Chinese Medicine, China

Weilin Liu is a distinguished professor at the Institute of Rehabilitation Industry, Fujian University of Traditional Chinese Medicine. His primary research focuses on the rehabilitation of cognitive impairments in elderly individuals and stroke patients, particularly through non-drug therapies like acupuncture and mind-body exercises. Liu’s work aims to explore the neuromolecular biological mechanisms underlying cognitive decline and synaptic plasticity, providing new insights into therapeutic strategies for cognitive impairments. With over 30 academic papers published, he is recognized as one of the top young talents in China, actively contributing to both scientific research and the advancement of rehabilitation methods. Liu has held prominent editorial positions, including associate editor-in-chief of Frontiers in Cellular Neuroscience, and has received multiple awards, including the Science and Technology Award from the Chinese Rehabilitation Medicine Association. His research is grounded in the pursuit of practical, non-invasive solutions to neurological rehabilitation, with a special focus on understanding and repairing cognitive dysfunctions.

Professional Profile

Education

Weilin Liu completed his undergraduate and graduate education at leading institutions in China, where he developed a strong foundation in traditional Chinese medicine and neuroscience. Liu later earned his Ph.D. in a relevant field, which equipped him with the necessary expertise to investigate cognitive impairments and their rehabilitation. His academic background has been pivotal in shaping his research approach, combining both modern scientific methods and traditional Chinese healing techniques. This academic experience provided him with the necessary tools to understand the biological mechanisms of cognitive decline and to innovate in non-pharmacological interventions like acupuncture. Liu’s education has supported his development into a leading researcher in his field, emphasizing the integration of different scientific disciplines to address complex neurological issues.

Professional Experience

Weilin Liu has had a distinguished professional career, contributing significantly to the field of cognitive rehabilitation. He holds a professorship at the Institute of Rehabilitation Industry at Fujian University of Traditional Chinese Medicine, where he has been a key figure in both academic research and practical applications in the field of rehabilitation. Liu has led multiple research projects focused on the neurological mechanisms of cognitive impairment and rehabilitation, particularly in elderly individuals and stroke patients. His professional experience extends to significant leadership roles in scientific journals, including serving as associate editor-in-chief of Frontiers in Cellular Neuroscience and a young editorial board member of Aging and Disease. Liu’s professional expertise spans across neurology, rehabilitation, and traditional Chinese medicine, making him a well-rounded and influential figure in his field.

Research Interests

Weilin Liu’s research interests primarily lie in the rehabilitation of cognitive impairments, particularly in elderly populations and stroke patients. His work focuses on non-drug therapies, such as acupuncture and mind-body exercises, as well as the underlying neuromolecular biological mechanisms that contribute to cognitive decline. Liu is particularly interested in the role of synaptic plasticity in cognitive impairment and the potential for repairing damage through innovative therapeutic interventions. His research also explores the broader neurobiological mechanisms that underlie conditions like Alzheimer’s disease and stroke-related cognitive dysfunctions. Liu’s work is at the intersection of traditional Chinese medicine and modern neuroscience, with a focus on non-invasive, practical therapies that can be applied to real-world clinical settings.

Research Skills

Weilin Liu has developed a wide array of research skills throughout his career. He is highly skilled in experimental design and implementation, with a focus on preclinical animal models used to study cognitive impairments and their rehabilitation. Liu’s expertise includes neurobiology, synaptic plasticity, and neuromolecular biology, which he uses to explore the mechanisms behind cognitive decline. He is proficient in techniques such as electroacupuncture, optogenetics, and behavioral testing, which are central to his research on cognitive rehabilitation. Liu’s interdisciplinary approach combines traditional Chinese medicine with cutting-edge neuroscience, allowing him to develop novel therapeutic interventions. Additionally, his leadership roles in scientific journals demonstrate his skills in research dissemination and academic collaboration, ensuring the impact of his work on a global scale.

Awards and Honors

Weilin Liu has received numerous awards and honors in recognition of his groundbreaking work in the field of cognitive rehabilitation. Among the most notable are the first prize of the Science and Technology Award from the Chinese Rehabilitation Medicine Association and the Fujian Youth Science and Technology Award. Liu’s exceptional research achievements have also earned him the Fujian Yunsheng Youth Science and Technology Award, among others. His recognition as one of the top young talents in China’s national talent programs, including the “Young Eagle Program” in Fujian Province, highlights his prominence in the scientific community. These accolades underscore the impact of Liu’s research and his leadership within the fields of rehabilitation and neuroscience, particularly his innovative work on non-pharmacological treatments for cognitive impairments.

Conclusion

Weilin Liu is a pioneering figure in the field of cognitive rehabilitation, with a focus on non-drug therapies such as acupuncture and mind-body exercises. His interdisciplinary approach, combining traditional Chinese medicine with modern neuroscience, allows for novel therapeutic strategies that address cognitive impairments in elderly individuals and stroke patients. Liu’s academic and professional experience has earned him numerous accolades and leadership roles in scientific publishing, further cementing his reputation as a top researcher in his field. With over 30 published papers and several prestigious awards, Liu’s contributions to rehabilitation science are significant and impactful. His future research holds promise for further advancements in cognitive rehabilitation, particularly in non-invasive, accessible therapies that could transform clinical practices worldwide.

Publications Top Notes

  1. In Situ Recovery of Serotonin Synthesis by a Tryptophan Hydroxylase-Like Nanozyme for the Treatment of Depression
    Authors: Xiao Fang, Yue Wu, Yaling Dai, Chunhua Lu, Huanghao Yang
    Year: 2025

  1. Acute Treatment with Salvianolic Acid A Produces Neuroprotection in Stroke Models by Inducing Excitatory Long-Term Synaptic Depression
    Authors: Jinnan Li, Niya Wang, Qi Huang, Baoci Shan, Lin Xu
    Year: 2025

  2. Tai Chi-Induced Exosomal LRP1 is Associated With Memory Function and Hippocampus Plasticity in aMCI Patients
    Authors: Miaoran Lin, Weilin Liu, Chuyi Ma, Zhifu Wang, Lidian Chen
    Year: 2024
    Citations: 4

  3. Investigating combined acupuncture and transcranial direct current stimulation in patients with poststroke shoulder pain from China: protocol for a randomised controlled trial
    Authors: Jincheng Chen, Zhigang Lin, Shuijin Chen, Yijing Jiang, Shanli Yang
    Year: 2024
    Citations: 1

  1. Electroacupuncture activates AMPKα1 to improve learning and memory in the APP/PS1 mouse model of early Alzheimer’s disease by regulating hippocampal mitochondrial dynamics
    Authors: Weiwei Jia, Huawei Lin, Minguang Yang, Cong Chen, Weilin Liu
    Year: 2024

  2. Electroacupuncture improves vascular cognitive impairment no dementia: A Randomized Clinical Trial
    Authors: Ruizhu Lin, Yaling Dai, Jianfeng Xu, Weilin Liu, Lidian Chen
    Year: 2024
    Citations: 2

  3. Gut microbiota and skeletal muscle protein metabolism in sarcopenia: research progress
    Authors: Qing Xiang, Yue Hu, Weilin Liu
    Year: 2024

  1. Electroacupuncture regulates Rab5a-mediating NGF transduction to improve learning and memory ability in the early stage of AD mice
    Authors: Jianhong Li, Minguang Yang, Yaling Dai, Jing Tao, Weilin Liu
    Year: 2024
    Citations: 1

  1. Effects of Exercise Training Under Hypoxia Versus Normoxia on Cognitive Function in Clinical and Non-Clinical Populations: A Systematic Review and Meta-analysis
    Authors: Yanting Lin, Jiamin Yan, Xiaoqin Guo, Weilin Liu, Lidian Chen
    Year: 2024
    Citations: 3

Mariana Udo | Neuroscience | Best Researcher Award

Dr. Mariana Udo | Neuroscience | Best Researcher Award

Postdoctoral Fellow at University of Texas Health, United States

Dr. Mariana Sayuri Berto Udo is a dedicated researcher with extensive expertise in neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. Currently a Postdoctoral Fellow at the Department of Neurology at Louisiana State University Health Sciences Center (LSU Health Shreveport), her work focuses on understanding vascular dementia and related pathways. Dr. Udo’s career spans multiple countries, including Brazil, Japan, and the United States, reflecting her global research perspective. She has secured prestigious funding from organizations such as the American Heart Association and has earned recognition for her scientific contributions. Dr. Udo has also served in academic mentorship, professional service, and research collaborations, making her a well-rounded scientist in her field.

Professional Profile

Education

Dr. Udo earned her Ph.D. (2013–2018) and MSc. (2010–2012) in Clinical and Toxicological Analysis from the University of São Paulo, Brazil, after completing her B.S. in Pharmaceutical Science at Methodist University of Piracicaba (2002–2006). She also obtained a certification in Clinical and Analytical Toxicology from the University of Campinas in 2007. Currently, she is a Postdoctoral Fellow at LSU Health Shreveport (2021–present), advancing her expertise in neurology. Her multidisciplinary education underlines her comprehensive understanding of pharmaceutical science, toxicology, and neurobiology.

Professional Experience

Dr. Udo has held various academic and research roles. As a Research Assistant at Asahikawa Medical University in Japan (2019–2021), she contributed to projects on neurophysiology and pharmacology. From 2013 to 2018, she was a lecturer at the Psychoanalytic Research Center, São Paulo, Brazil, where she taught neurophysiology and pharmacology. Additionally, she has contributed to scientific committees and evaluation boards, reflecting her dedication to advancing education and research.

Research Interests

Dr. Udo’s research interests encompass neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. She is particularly focused on the organization and derangement of the microvasculature and the role of lipid rafts in neurodegenerative processes. Her work aims to elucidate mechanisms that contribute to vascular dementia, with an emphasis on improving understanding and treatment of age-related neurological disorders.

Research Skills

Dr. Udo is proficient in advanced research methodologies, including molecular and cellular biology, neurophysiological studies, and toxicological analysis. She has experience with preclinical models, pharmacological assessments, and data analysis related to neurodegeneration and cognition. Her ability to design and execute complex experiments, coupled with her analytical skills, has been instrumental in advancing her research objectives.

Awards and Honors

Dr. Udo has received numerous accolades for her work, including the Best Oral Presentation Award at the XXIV Benjamin Eurico Malucelli Scientific Meeting in 2015. She has also secured prestigious funding, such as the American Heart Association Postdoctoral Fellowship (2024–2025) and the Malcolm Feist Cardiovascular Research Fellowship (2023–2024). These recognitions reflect her significant contributions to the field of neurology and toxicology.

Conclusion

Dr. Mariana Sayuri Berto Udo is an excellent candidate for the Best Researcher Award due to her diverse academic background, international research experience, substantial funding achievements, and focus on impactful areas of neurology and toxicology. To further enhance her application, she could focus on increasing her publication record in high-impact journals and expanding global collaborations. Overall, her research and contributions make her a strong contender for this prestigious recognition.

Publication Top Notes

  1. Prenatal exposure to a low fipronil dose disturbs maternal behavior and reflex development in rats
    Authors: MSB Udo, TM Sandini, TM Reis, MM Bernardi, HS Spinosa
    Journal: Neurotoxicology and Teratology
    Year: 2014
    Citations: 51
  2. Desenvolvimento e estudos preliminares de estabilidade de formulações fotoprotetoras contendo Granlux GAI-45 TS
    Authors: M Chorilli, MS Udo, ME Cavallini, GR Leonardi
    Journal: Revista de Ciências Farmacêuticas Básica e Aplicada
    Year: 2006
    Citations: 36
  3. Prenatal exposure to integerrimine N-oxide impaired the maternal care and the physical and behavioral development of offspring rats
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, MM Bernardi, HS Spinosa
    Journal: International Journal of Developmental Neuroscience
    Year: 2014
    Citations: 22
  4. Prenatal exposure to fipronil disturbs maternal aggressive behavior in rats
    Authors: JZ Magalhães, MSB Udo, AM Sánchez-Sarmiento, MPN Carvalho, …
    Journal: Neurotoxicology and Teratology
    Year: 2015
    Citations: 20
  5. M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product
    Authors: RCT Garcia, LMM Dati, LH Torres, MAA da Silva, MSB Udo, FMF Abdalla, …
    Journal: Scientific Reports
    Year: 2015
    Citations: 17
  6. Senecio brasiliensis e alcaloides pirrolizidínicos: toxicidade em animais e na saúde humana
    Authors: TM Sandini, MSB Udo, H de Souza Spinosa
    Journal: Biotemas
    Year: 2013
    Citations: 16
  7. Prenatal exposure to integerrimine N-oxide enriched butanolic residue from Senecio brasiliensis affects behavior and striatal neurotransmitter levels of rats in adulthood
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, D Sanches, MM Bernardi, JC Flório, …
    Journal: International Journal of Developmental Neuroscience
    Year: 2015
    Citations: 13
  8. Fipronil: uses, pharmacological and toxicological features
    Authors: JZ Magalhães, TM Sandini, MSB Udo, A Fukushima, H de Souza-Spinosa
    Journal: Revinter
    Year: 2018
    Citations: 12
  9. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer’s disease
    Authors: GA Clemons, AC Silva, CH Acosta, MSB Udo, V Tesic, KM Rodgers, …
    Journal: Journal of Cellular Physiology
    Year: 2024
    Citations: 11
  10. Anhydroecgonine methyl ester, a cocaine pyrolysis product, contributes to cocaine-induced rat primary hippocampal neuronal death in a synergistic and time-dependent manner
    Authors: MSB Udo, MAA da Silva, S de Souza Prates, LF Dal’Jovem, …
    Journal: Archives of Toxicology
    Year: 2021
    Citations: 9